teva pharmaceutical-sp adr
Director, Chairman of Corporate Responsibility Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee and Member of Audit Committee, Teva Pharmaceutical Industries Limited
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Mr. Ory Slonim serves as a Senior Vice President of Variety International. Mr. Slonim is an Advocate and has been an Attorney in private practice since 1970. He served as a special Consultant to the Israeli Defense Minister from 1989 to 2006. He served as President of "Variety Club", Israel from 1994 to 2007. He has been the Chairman of Variety Club in Israel since 2006. He serves as Vice Chairman of Harel Insurance Investments & Financial Services Ltd. He served as ...
5 Basel StreetPhone: 972 3 926 7267
Petach Tikva, -- 49131
Fax: 972 3 923 4050
Board Members Memberships*
Former Director, Member of Committee for the Accompaniment of Financial Statements and Substitute Chairman of Migdal Insurance Company Ltd
Director, Chairman of Corporate Responsibility Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee and Member of Audit Committee
Hebrew University of Jerusalem
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|